110 related articles for article (PubMed ID: 15327020)
21. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.
Seifert WE; Foxx JL; Butler IJ
Ann Neurol; 1980 Jul; 8(1):38-42. PubMed ID: 6157351
[TBL] [Abstract][Full Text] [Related]
22. [The effect of amino acids on neurotransmitter metabolites in the cerebrospinal fluid].
Zeman J; Böswart J
Cas Lek Cesk; 1991 May; 130(14):425-7. PubMed ID: 1712669
[TBL] [Abstract][Full Text] [Related]
23. Individual differences in basal cisternal cerebrospinal fluid 5-HIAA and HVA in monkeys. The effects of gender, age, physical characteristics, and matrilineal influences.
Raleigh MJ; Brammer GL; McGuire MT; Pollack DB; Yuwiler A
Neuropsychopharmacology; 1992 Dec; 7(4):295-304. PubMed ID: 1282317
[TBL] [Abstract][Full Text] [Related]
24. Bovine spastic paralysis: cerebrospinal fluid concentrations of homovanillic acid and 5-hydroxyindoleacetic acid in normal and spastic calves.
De Ley G; De Moor A
Am J Vet Res; 1975 Feb; 36(2):227-8. PubMed ID: 1111389
[TBL] [Abstract][Full Text] [Related]
25. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
Scheinin M
Med Biol; 1985; 63(1):1-17. PubMed ID: 2582215
[TBL] [Abstract][Full Text] [Related]
26. The concentrations of monoamine metabolites and neuropeptides in the cerebrospinal fluid of obese women with different body fat distribution.
Strömbom U; Krotkiewski M; Blennow K; Månsson JE; Ekman R; Björntorp P
Int J Obes Relat Metab Disord; 1996 Apr; 20(4):361-8. PubMed ID: 8680464
[TBL] [Abstract][Full Text] [Related]
27. 5-Hydroxyindoleacetic acid and homovanillic acid concentrations in cerebrospinal fluid in patients with Alzheimer's disease, depression and mild cognitive impairment.
Stuerenburg HJ; Ganzer S; Müller-Thomsen T
Neuro Endocrinol Lett; 2004 Dec; 25(6):435-7. PubMed ID: 15665806
[TBL] [Abstract][Full Text] [Related]
28. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
Yoshino K
No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264
[TBL] [Abstract][Full Text] [Related]
29. Homovanillic acid and 5-hydroxyindoleacetic acid in the ventricular CSF of comatose patients with obstructive hydrocephalus.
Inagawa T; Ishikawa S; Uozumi T
J Neurosurg; 1980 May; 52(5):635-41. PubMed ID: 6154788
[TBL] [Abstract][Full Text] [Related]
30. 5-Hydroxyindolacetic acid and homovanillic acid are not involved in the cerebrospinal fluid after a seizure in patients with Delirium Tremens.
Couvreur G; Demougeot C; Maugras C; Marie C; Beley P; Giroud M
Neurol Res; 2002 Sep; 24(6):599-600. PubMed ID: 12238628
[TBL] [Abstract][Full Text] [Related]
31. Analysis of neurotransmitter metabolite concentrations in canine cerebrospinal fluid.
Vaughn DM; Coleman E; Simpson ST; Satjawatcharaphong C
Am J Vet Res; 1988 Aug; 49(8):1302-6. PubMed ID: 2459997
[TBL] [Abstract][Full Text] [Related]
32. Gradients of concentrations of tryptophan and 5-hydroxyindoleacetic acid (5-HIAA) in cerebrospinal fluid (CSF).
Sourkes TL; Young SN; Garelis E; Lal S
Acta Vitaminol Enzymol; 1975; 29(1-6):97-9. PubMed ID: 1244132
[TBL] [Abstract][Full Text] [Related]
33. Substance P, thyrotropin-releasing hormone, and monoamine metabolites in cerebrospinal fluid in sleep apnea patients.
Gislason T; Hedner J; Terenius L; Bisette G; Nemeroff CB
Am Rev Respir Dis; 1992 Sep; 146(3):784-6. PubMed ID: 1381567
[TBL] [Abstract][Full Text] [Related]
34. Stability of monoamine metabolites in human cerebrospinal fluid.
Langlais PJ; Bird ED; McEntee WJ
Ann Neurol; 1982 Jul; 12(1):48-51. PubMed ID: 6180677
[TBL] [Abstract][Full Text] [Related]
35. Early death and CSF monoamine metabolites in schizophrenia spectrum psychosis.
Carlborg A; Jokinen J; Nordström AL; Jönsson EG; Nordström P
Nord J Psychiatry; 2011 Apr; 65(2):101-5. PubMed ID: 20662686
[TBL] [Abstract][Full Text] [Related]
36. Monoamine metabolites in successive samples of spinal fluid. A comparison between healthy volunteers and patients with multiple sclerosis.
Andersen O; Johansson BB; Svennerholm L
Acta Neurol Scand; 1981 Apr; 63(4):247-54. PubMed ID: 6163303
[TBL] [Abstract][Full Text] [Related]
37. The influence of the lying and sitting positions on the gradients of 5-HIAA and HVA in lumbar cerebrospinal fluid.
Gateless D; Stanley M; Träskman-Bendz L; Gilroy J
Biol Psychiatry; 1984 Nov; 19(11):1585-9. PubMed ID: 6083808
[No Abstract] [Full Text] [Related]
38. Elevated biopterin and homovanillic acid levels in cerebrospinal fluid from children with aseptic meningitis.
Komori H; Matsuishi T; Yamada S; Ichikawa K; Amamoto M; Yamashita F
J Child Neurol; 1994 Jan; 9(1):22-5. PubMed ID: 8151076
[TBL] [Abstract][Full Text] [Related]
39. Pathogenetic role of monoamine metabolism in complex febrile seizures.
Nishimura K; Hara M
Pediatr Neurol; 1999 Aug; 21(2):553-6. PubMed ID: 10465142
[TBL] [Abstract][Full Text] [Related]
40. Cerebrospinal fluid neuropeptides and monoaminergic transmitters in patients with trigeminal neuralgia.
Strittmatter M; Grauer M; Isenberg E; Hamann G; Fischer C; Hoffmann KH; Blaes F; Schimrigk K
Headache; 1997 Apr; 37(4):211-6. PubMed ID: 9150615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
